Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy
Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy
复制标题
romiplostim 和静脉注射免疫球蛋白联合治疗可增加血小板计数，促进对单一疗法无反应的难治性免疫性血小板减少性紫癜患者的脾切除术
DOI：
--
复制
发表时间：
2012
影响因子：
6.5
通讯作者：
Motoji T
中科院分区：
文献类型：
--
作者：
Mitsuhashi K;Ishiyama M;Imai Y;Shiseki M;Mori N;Teramura M;Seshimo A;Motoji T
